Inside Science
/
Article

Macaque Monkeys, Predictions for COVID-19, and a Beetle

OCT 29, 2020
A month’s worth of cool science stories.
Macaque Monkeys, Prediction of Peak COVID-19 Months, and a Beetle

(Inside Science) -- In this monthly recap, Alistair Jennings from Inside Science sums up some of the most interesting recent science topics:

Macaque monkeys treated with the experimental drug called REGN-COV2 harbored less of the SARS-CoV-2 virus than untreated ones -- and when the researchers examined their lung tissue, they found less damage and fewer signs of pneumonia. The researchers then tested the treatment on hamsters, who develop a more severe form of COVID-19, the disease caused by the new coronavirus. But here, there was a bit of a mystery: Treated hamsters had less pneumonia in their lungs but no significant change in the amount of virus in the system.

A group of Norway-based scientists have published a model that predicts COVID-19 cases will continue rise into the winter -- peaking in December and January -- if we don’t make adequate interventions. But there is some good news: The pandemic has led to the biggest drop in carbon dioxide emissions in over a century.

The diabolical ironclad beetle. This beetle’s exoskeleton is so strong that it can withstand being run over by a car and resist the bite force of its predators.

References

REGN-COV2

Covid and winter

CO2 emissions drop

Seagrass recovery

Ironclad beetle

More Science News
/
Article
Advanced metering infrastructure, Internet of Things devices, and machine learning algorithms can improve communication between distributed power generation sources.
/
Article
A new method uses condenser microphones and neural networks to estimate droplet radius from resonant frequency.
FYI
/
Article
The lawsuit is driven by Trump’s effort to bar unions at NASA on the grounds that they hinder the agency’s “national security mission.”
/
Article
WASHINGTON, Oct. 21, 2025 — Measuring how well blood flows to the brain is crucial for understanding a wide range of neurological issues, from strokes to migraines […]